查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1537599

全球碘市場：市場佔有率分析、產業趨勢/統計、成長預測（2024-2029）

Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2024年全球碘市場規模為40.64千噸，預計2029年將達到53.06千噸，在預測期間（2024-2029年）複合年成長率為5.48%。

碘市場

主要亮點

  • 短期內，碘需求預計將受到X光顯影劑需求增加以及碘缺乏增加導致的碘攝取需求增加的推動。
  • 然而，過量攝取導致的碘毒性和健康相關問題是研究市場成長的主要限制因素。
  • 另一方面，對除生物劑的需求不斷成長以及對碘回收的需求不斷成長可能會在未來幾年創造利潤豐厚的市場機會。
  • 歐洲已成為最大的碘市場，而亞太地區預計在 2024 年至 2029 年期間將呈現最高的複合年成長率。

碘市場趨勢

醫療領域預計將主導市場

  • 碘是醫療產業的重要元素，在診斷和治療方面有多種用途。最常見的用途是生產防腐劑和消毒劑，碘具有殺死細菌、病毒和真菌的能力，使其成為預防感染疾病的有效工具。
  • 此外，碘也用於製造用於醫學影像處理（如電腦斷層掃描、X 光和血管造影術）的放射性顯影劑。這些材料含有碘原子，可以吸收 X光，使身體的內部結構在生成的圖像中可見。
  • 碘原子序數大、毒性低、易於與有機化合物綴合，因此隨著X光顯影劑需求的增加，其需求量也隨之增加。
  • 對於在市政水處理不可靠的地區旅行或工作的人來說，碘是一種簡單、有效且經濟高效的水消毒方法。在對飲用水進行消毒時，在緊急情況下和旅行者中通常會使用錠劑和溶液形式的碘。近年來，隨著出行人數的增加，作為消毒劑的碘的需求量也隨之增加。
  • 2024年1月，據馬裡蘭大學醫學院稱，在一項由馬裡蘭大學醫學院研究人員共同主導的大型多中心臨床試驗中，一種含碘消毒劑（酒精中的Iodine Povacrilex）經常被發現與使用的另一種皮膚消毒劑相比，四肢骨折患者的術後感染疾病減少了約四分之一。
  • 2024年1月，中國核能工業集團公司（CNNC）開始建造強大的溶液型醫用同位素試驗堆。該計劃將生產碘 131 和碘 125 等醫用同位素。醫用同位素是用於醫療目的的典型放射性同位素。例如，碘 131 用於放射治療和診斷成像。它也用於破壞功能障礙的甲狀腺組織和許多其他醫療用途。根據中核集團介紹，核子反應爐建成後，碘131年產能將達到2萬居里，超過目前國內需求。
  • 根據Astra Zeneca預計，2024年北美藥品銷售額預計將達6,330億美元，位居第一，歐盟（不包括英國）以2,870億美元位居第二，東南亞和東亞則以232美元位居第二。此外，2020年藥品總支出為12,652億美元，預計2025年收益為15,950億美元。
  • 因此，由於上述因素，醫療終端用戶產業預計將在2024-2029年期間主導碘市場。

預計歐洲將主導市場

  • 預計2024年至2029年歐洲將主導碘市場。德國、英國和義大利等國家的動物飼料、醫療和除生物劑應用對碘的需求不斷增加。
  • 根據德國動物飼料協會（DVT）的數據，2023日曆年德國飼料產量為2,170萬噸（mmt），約36萬噸（mt），比前12個月下降1.6%。 DVT主席宣布，與前一年同期比較意味著德國飼料產業長期萎縮的局面得到部分緩解。國內飼料產量下降的主要原因是生豬飼料銷量下降。 2023 年該產業的產量將減少約 50 萬噸（5.8%）至 800 萬噸。
  • 此外，德國的污水再處理和回收率是歐洲最高的。 96%以上的家庭和公共設施污水排放至附近污水處理廠處理。隨著該國廢水處理量的增加，預計這些工廠將在 2024 年至 2029 年間使用大量碘基除生物劑。
  • 醫療產業是碘的最大消費產業。英國製藥工業協會2023年12月公佈的資料顯示，英國生命科學產業2022年銷售額將為1,081億歐元（1,154億美元），比2022年的959億歐元（1,023.7億美元）成長13 %。自2013年以來，銷售額一直呈現成長趨勢，但2021年至2022年成長迅速。生物製藥的核心細分市場銷售額最高，佔生命科學產業總銷售額的43%。其次是生物製藥服務和供應部門以及醫療技術核心部門，各佔 2022 年銷售額的 25%。這些趨勢也會影響碘的消費量。
  • 義大利製藥業擁有龐大且可靠的製造基地，擁有約 67,000 名敬業的員工隊伍。它技術先進，不僅在歐洲而且在世界上都處於主導地位。
  • 根據Farmindustria-Prometeia 2023的調查資料，義大利製藥業是義大利經濟的驅動力。 2023年，產業價值將達到500億歐元（553億美元）。義大利藥品生產在歐洲製藥業中扮演重要角色。根據 Farmindustria-Prometeia 2023 研究，該產業的產量在 2023 年比 2022 年增加了 7.3%。
  • 由於上述因素，預計2024年至2029年歐洲碘市場將大幅成長。

碘業概況

碘市場本質上是部分一體化的。市場主要參與者（排名不分先後）包括 SQM SA、ISE CHEMICALS CORPORATION、Cosayach、Iochem Corporation、Algorta Norte 等。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 調查先決條件
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素
    • X光顯影劑需求增加
    • 碘缺乏症增加
  • 抑制因素
    • 碘毒性和健康問題
  • 價值鏈分析
  • 波特五力分析
    • 供應商的議價能力
    • 買方議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章市場區隔（基於數量的市場規模）

  • 來源
    • 地下鹵水
    • 卡利甚礦石
    • 回收
    • 海藻
  • 形式
    • 無機鹽和錯合
    • 有機化合物
    • 元素和同位素
  • 目的
    • 餵食
    • 醫療保健
    • 除生物劑
    • 光學偏光片
    • 氟化學
    • 尼龍
    • 其他用途
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 義大利
      • 法國
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東/非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東/非洲

第6章 競爭狀況

  • 併購、合資、聯盟、協議
  • 市場佔有率(%)分析
  • 主要企業策略
  • 公司簡介
    • Algorta Norte
    • Calibre Chemicals Pvt. Ltd
    • Cosayach
    • Deep Water Chemicals
    • Eskay Iodine
    • Glide Chem Private Limited
    • Godo Shigen Co. Ltd
    • Iochem Corporation
    • Iofina
    • ISE Chemicals Corporation
    • Itochu Chemical Frontier Corporation
    • K&O Energy Group Inc.
    • Nippoh Chemicals Co. Ltd
    • Parad Corporation Pvt. Ltd
    • Proto Chemical Industries
    • Salvi Chemical Industries Ltd
    • Samrat Pharmachem Limited
    • SQM SA
    • TOHO Earthtech Inc.

第7章 市場機會及未來趨勢

  • 碘回收需求不斷增加
  • 增加除生物劑的使用
簡介目錄
Product Code: 69271

The Iodine Market size is estimated at 40.64 kilotons in 2024, and is expected to reach 53.06 kilotons by 2029, growing at a CAGR of 5.48% during the forecast period (2024-2029).

Iodine - Market

Key Highlights

  • In the short term, the increasing demand for X-ray contrast media and increasing requirements for iodine uptake with growing iodine deficiency among people are expected to drive the demand for iodine.
  • However, the toxicity of iodine and health-related issues due to excessive consumption pose major restraints to the studied market growth.
  • On the other hand, the rising demand for biocides and the growing demand for recycling iodine are likely to create lucrative market opportunities in the coming years.
  • Europe emerged as the largest market for iodine, while Asia-Pacific is expected to witness the highest CAGR between 2024 and 2029.

Iodine Market Trends

The Medical Segment is Expected to Dominate the Market

  • Iodine is a crucial element in the medical industry, with many applications in diagnosis and treatment. Its most common use is in producing antiseptics and disinfectants, where iodine's ability to kill bacteria, viruses, and fungi makes it an effective tool for preventing infections.
  • In addition, iodine is used to produce radiocontrast materials, which are used in medical imaging procedures such as CT scans, X-rays, and angiograms. These materials contain iodine atoms, which absorb X-rays and make the internal structures of the body visible in the resulting images.
  • The demand for iodine has been increasing over the rising need for X-ray contrast media because of its high atomic number, low toxicity, and ease of adjunction with organic compounds.
  • Iodine is a simple, effective, and cost-efficient means of water disinfection for people who travel or work in areas where municipal water treatment is unreliable. In terms of the disinfection of drinking water, iodine is commonly used in the form of tablets or solutions during emergencies and by travelers. As the number of travelers has increased in recent years, the demand for iodine as a disinfectant has also been increasing.
  • In January 2024, according to the University of Maryland School of Medicine, a large multicenter clinical trial co-led by the University of Maryland School of Medicine researchers found that an antiseptic containing iodine (iodine povacrylex in alcohol) resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic.
  • In January 2024, China National Nuclear Corporation (CNNC) started the construction of a powerful solution-type medical isotope test reactor. This initiative will produce Iodine-131 and iodine-125, among other medical isotopes. Medical isotopes are typical radioactive isotopes that are used for medical purposes. For example, iodine-131 is used for radiotherapy or imaging. It can also be used to destroy dysfunctional thyroid tissues and many other medical applications. According to CNNC, after completing the medical isotope reactor, which is estimated to be completed by 2027, it will attain an annual production capacity of 20,000 curies of iodine-131, surpassing the current domestic demand.
  • According to AstraZeneca, the projected pharmaceutical sales in 2024 are expected to be USD 633 billion for North America, holding the major share, followed by the European Union (excluding the United Kingdom) with USD 287 billion at the second position, followed by Southeast and East Asia and expected to register USD 232 billion. Also, the total spending on medicines in 2020 was USD 1,265.2 billion, which is expected to generate a revenue of USD 1,595 billion in 2025.
  • Hence, owing to the above-mentioned factors, the medical end-user industry is expected to dominate the market for iodine from 2024 to 2029.

Europe is Expected to Dominate the Market

  • Europe is expected to dominate the iodine market between 2024 and 2029. Countries like Germany, the United Kingdom, and Italy are seeing rising demand for iodine in animal feed, medical, and biocide applications.
  • According to the German Animal Feed Association (DVT), at 21.7 million metric tons (mmt), feed production in Germany in the 2023 calendar year was around 360,000 metric tons (mt), or 1.6% less than in the previous 12 months. The DVT President announced that the year-on-year contraction represents a partial easing in the long-term contraction in the German feed sector. The decline in total national feed output is attributed mainly to reduced sales of pig feeds. This segment's production was down approximately 500,000 mt or 5.8% to 8 mmt for 2023.
  • Moreover, Germany has the highest wastewater reprocessing and recycling rate in Europe. More than 96% of the wastewater from private households or public facilities is discharged into nearby sewage treatment plants for processing. With the country's increasing sewage water volume, these plants are expected to exploit a larger volume of iodine-based biocides between 2024 and 2029.
  • The medical industry is the largest consumer of iodine. According to data from the Association of the British Pharmaceutical Industry released in December 2023, businesses in the UK life sciences industry generated EUR 108.1 billion (USD 115.4 billion) in turnover in 2022, a 13% increase from the EUR 95.9 billion (USD 102.37 billion) turnover in 2022. Turnover has seen an upward trend since 2013 but increased sharply between 2021 and 2022. The sector that generated the highest turnover was the biopharmaceutical core sector, accounting for 43% of the total turnover generated across the life sciences industry. This was followed by the biopharmaceutical service and supply and medical technology core sectors, each accounting for 25% of turnover in 2022. Such trends affect the consumption of iodine.
  • The Italian pharmaceutical industry represents a vast and reliable manufacturing base with a dedicated workforce of around 67,000 people. It is technologically advanced and has a strong leadership position in Europe and beyond.
  • According to the data from the Farmindustria-Prometeia 2023 survey, the Italian pharmaceutical industry is the driving force of the country's economy. In 2023, the industry value reached EUR 50 billion (USD 55.3 billion). The Italian pharmaceutical production plays a vital role in Europe's pharmaceutical industry. The sector's output increased by 7.3% in 2023 compared to 2022, according to the Farmindustria-Prometeia 2023 survey.
  • Owing to the factors mentioned above, the market for iodine in Europe is projected to grow significantly between 2024 and 2029.

Iodine Industry Overview

The iodine market is partially consolidated in nature. Some of the major players in the market (not in any particular order) are SQM SA, ISE CHEMICALS CORPORATION, Cosayach, Iochem Corporation, and Algorta Norte.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Demand in X-ray Contrast Media
    • 4.1.2 Growing Iodine Deficiency Among People
  • 4.2 Restraints
    • 4.2.1 Toxicity of Iodine and Health-related Issues
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Source
    • 5.1.1 Underground Brine
    • 5.1.2 Caliche Ore
    • 5.1.3 Recycling
    • 5.1.4 Seaweeds
  • 5.2 Form
    • 5.2.1 Inorganic Salts and Complexes
    • 5.2.2 Organic Compounds
    • 5.2.3 Elementals and Isotopes
  • 5.3 Application
    • 5.3.1 Animal Feed
    • 5.3.2 Medical
    • 5.3.3 Biocides
    • 5.3.4 Optical Polarizing Films
    • 5.3.5 Fluorochemicals
    • 5.3.6 Nylon
    • 5.3.7 Other Applications
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 United Kingdom
      • 5.4.3.3 Italy
      • 5.4.3.4 France
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers And Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share (%) Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Algorta Norte
    • 6.4.2 Calibre Chemicals Pvt. Ltd
    • 6.4.3 Cosayach
    • 6.4.4 Deep Water Chemicals
    • 6.4.5 Eskay Iodine
    • 6.4.6 Glide Chem Private Limited
    • 6.4.7 Godo Shigen Co. Ltd
    • 6.4.8 Iochem Corporation
    • 6.4.9 Iofina
    • 6.4.10 ISE Chemicals Corporation
    • 6.4.11 Itochu Chemical Frontier Corporation
    • 6.4.12 K&O Energy Group Inc.
    • 6.4.13 Nippoh Chemicals Co. Ltd
    • 6.4.14 Parad Corporation Pvt. Ltd
    • 6.4.15 Proto Chemical Industries
    • 6.4.16 Salvi Chemical Industries Ltd
    • 6.4.17 Samrat Pharmachem Limited
    • 6.4.18 SQM SA
    • 6.4.19 TOHO Earthtech Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Increasing Demand for Recycling Iodine
  • 7.2 Rise in the Usage of Biocides